That's the question
Rated 5 out of 5 Lawrence B
The combined effects appeared to involve GHK-CUs matrix remodeling effects complementing the growth factors cellular proliferation effects
However, AOD 9604 faces a significant regulatory challenge
A pharmaceutical formulation comprising: an effective amount of cagrilintide and semaglutide, more than 10% w/v and less than 22% w/v, such as 10-20% w/v cyclodextrin of the hydroxypropyl-substituted alpha and/or beta type, said cyclodextrin comprising a minimum of about 0.4 and a maximum of about 1.0 hydroxypropyls per glucose unit, such as 0.58-1 .0 hydroxypropyls per glucose unit, about 3-30 mM histidine, about 10-40 mg/ml sorbitol, up to 2.0 mg/ml, such as up to 1 .5 mg/ml polysorbate 20 and/or 80, about 75-90% w/w water and having a pH of 5.6-6.0
[DOI] [PubMed] [Google Scholar] 65.Patel RV, Mistry BM, Shinde SK, Syed R, Singh V, Shin HS